QQ客服 官方微博 反馈留言

	The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier
	Shen, Shigang[1]; Li, Haiying[2]; Yang, Wenzhi[3]
刊名	DRUG DELIVERY
	2014
卷号	21期号:7页码:501-508
关键词	Cholesterol-modified pullulan epirubicin nanoparticles pharmacokinetics stability toxicity
ISSN号	1071-7544
DOI	http://dx.doi.org/10.3109/10717544.2014.895068
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5079710
专题	河北大学
作者单位	1.[1]Hebei Univ, Coll Chem & Environm Sci, Baoding 071002, Peoples R China. 2.[2]Hebei Univ, Coll Chem & Environm Sci, Baoding 071002, Peoples R China. 3.[3]Chinese Acad Med Sci, Peking Union Med Coll, Inst Biomed Engn, Tianjin, Peoples R China.
推荐引用方式 GB/T 7714	Shen, Shigang[1],Li, Haiying[2],Yang, Wenzhi[3]. The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier[J]. DRUG DELIVERY,2014,21(7):501-508.
APA	Shen, Shigang[1],Li, Haiying[2],&Yang, Wenzhi[3].(2014).The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier.DRUG DELIVERY,21(7),501-508.
MLA	Shen, Shigang[1],et al."The preliminary evaluation on cholesterol-modified pullulan as a drug nanocarrier".DRUG DELIVERY 21.7(2014):501-508.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。